Rocco De Vivo

Azienda ULSS8 Berica Distretto Est, 
Vicenza, IT 
Azienda ULSS8 Berica Distretto Est, 
Vicenza, IT 

Overview

Rocco De Vivo practices practicing medicine in Vicenza, Italy.

His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Ovarian Cancer, Extramammary Paget Disease, and Nephrectomy.

He is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Azienda ULSS8 Berica Distretto Est, Vicenza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
Enrollment Status: Completed
Publish Date: February 24, 2026
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Topotecan, Vinorelbine, Gemcitabine, Irinotecan, Pemetrexed
Study Phase: Phase 3

19 Total Publications

The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est).
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est).
Journal: Therapeutic advances in urology
Published: March 14, 2025

Frequently Asked Questions about Rocco De Vivo

Is Rocco De Vivo a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Rocco De Vivo is classified as an Experienced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rocco De Vivo participate in research or clinical trials?

Yes. Rocco De Vivo has published 19 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Rocco De Vivo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Vivo's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile